These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7097531)

  • 21. Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product.
    Qureshi SA; McGilveray IJ
    Eur J Pharm Sci; 1999 Feb; 7(3):249-58. PubMed ID: 9845813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of operational characteristics of different dissolution testing systems.
    Hardwidge EA; Sarapu AC; Laughlin WC
    J Pharm Sci; 1978 Dec; 67(12):1732-5. PubMed ID: 722490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effect of Sampling Cannula on In Vitro Dissolution Testing with USP Paddle Method.
    Gao Z; Smith A
    AAPS J; 2023 Apr; 25(3):46. PubMed ID: 37101085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspirin--a national survey IV: In vitro dissolution of aspirin formulations.
    Juhl WE; Kirchhoefer RD
    J Pharm Sci; 1980 Aug; 69(8):967-70. PubMed ID: 7400948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel off-center paddle impeller (OPI) dissolution testing system for reproducible dissolution testing of solid dosage forms.
    Wang Y; Armenante PM
    J Pharm Sci; 2012 Feb; 101(2):746-60. PubMed ID: 22083630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated analytical systems for drug development studies. 3. Multivessel dissolution testing system based on microdialysis sampling.
    Shah KP; Chang M; Riley CM
    J Pharm Biomed Anal; 1995 Sep; 13(10):1235-41. PubMed ID: 8562595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dissolution determination in the rotating flask model. Effect of rotation rate and fluid volume on the solubility determination of standard test tablets in the Resotest dissolution tester].
    Koch HP; Pfeifer G
    Pharmazie; 1983 May; 38(5):318-23. PubMed ID: 6611628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple fiber-optic dual-beam UV/Vis system with application to dissolution testing.
    Johansson J; Cauchi M; Sundgren M
    J Pharm Biomed Anal; 2002 Jul; 29(3):469-76. PubMed ID: 12062647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peristaltic dissolution apparatus: prediction of relative in vivo performance of prednisone tablets in humans.
    Simmons DL; Legore AA; Picotte P
    J Pharm Sci; 1980 Feb; 69(2):220-2. PubMed ID: 7359333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of vessel geometric irregularity on dissolution test results.
    Gao Z; Ahadi S; Moore TW; Doub WH; Westenberger BJ; Buhse LF
    J Pharm Sci; 2011 Mar; 100(3):1093-101. PubMed ID: 20803604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new concept for automated drug-dissolution study.
    Ferrari A; Khoury AJ
    Ann N Y Acad Sci; 1968 Nov; 153(2):660-71. PubMed ID: 5261175
    [No Abstract]   [Full Text] [Related]  

  • 32. Computerized automated system for determining dissolution rate profiles for solid dosage forms.
    Cioffi FJ; Abdou HM; Warren AT
    J Pharm Sci; 1976 Aug; 65(8):1234-40. PubMed ID: 978444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An automated sampling device for dissolution testing.
    Carrie TR; Sanders GA
    J Pharm Sci; 1983 Aug; 72(8):976-8. PubMed ID: 6620165
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shear distribution and variability in the USP Apparatus 2 under turbulent conditions.
    Kukura J; Baxter JL; Muzzio FJ
    Int J Pharm; 2004 Jul; 279(1-2):9-17. PubMed ID: 15234789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrodynamic investigation of USP dissolution test apparatus II.
    Bai G; Armenante PM; Plank RV; Gentzler M; Ford K; Harmon P
    J Pharm Sci; 2007 Sep; 96(9):2327-49. PubMed ID: 17573698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of USP calibrator tablets in flow-through cell apparatus.
    Bielen N
    Int J Pharm; 2002 Feb; 233(1-2):123-9. PubMed ID: 11897416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Continuous in situ monitoring of the dissolution rate of solid pharmaceutical preparations using a multiple channel fiber-optic chemical sensor].
    Zhang QM; Ge JH; Mai ED; Su QZ; Chen J
    Yao Xue Xue Bao; 2003 Apr; 38(4):294-7. PubMed ID: 12889132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement uncertainty arising from sampling and analytical steps of dissolution test of prednisone tablets.
    Sano AY; Lourenço FR
    J Pharm Biomed Anal; 2023 Sep; 234():115501. PubMed ID: 37348366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a biphasic dissolution test for Deferasirox dispersible tablets and its application in establishing an in vitro-in vivo correlation.
    Al Durdunji A; AlKhatib HS; Al-Ghazawi M
    Eur J Pharm Biopharm; 2016 May; 102():9-18. PubMed ID: 26898545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.